Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

Check out executive hires from SnapNurse, Almaden Genomics, Dr. Evidence, Healthy.io, Wheel, and Sage Bionetworks.

At the 5th annual HLTH conference in Las Vegas, 14 healthcare executives from companies such as Babson Diagnostics to Wheel responded to questions such as what’s the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.

Check out new developments from Opala, Wheel, GoodRx, Fathom, Tivic Health, and more.

The Covid-19 pandemic has propelled virtual healthcare into our daily lives, although the quality of that experience varies. But one emerging trend from the scaling of telehealth is virtual-first care, as Wheel CEO and founder Michelle Davey explained.

The Future of Virtual-First Care eBook, sponsored by Wheel, explores some of the challenges and trends in virtual-first care. It also offers clues as to how healthcare stakeholders envision the future of virtual health.

In a webinar sponsored by Wheel, health tech executives will explore how telehealth is increasingly becoming the first point of interaction between patients and providers and the potential for hybrid care models to improve the patient experience, health outcomes, and deliver cost savings.

The new infusion brings Wheel’s total funding to $216 million at a time when more companies understand the need to have an on-demand consumer/patient-facing telemedicine service that Wheel possesses but may not necessarily want to build it from the ground up.

What draws investors to healthcare startups? In this series in the runup to MedCity INVEST in Chicago, we’ll highlight these perspectives. If you’re a startup in pharma tech, value-based care and care coordination, diagnostics or remote patient monitoring/smart devices, apply to our Pitch Perfect contest today.

Wheel, an Austin-based telehealth startup, raised $50 million in series B funding. The company builds networks of clinicians behind several well-known digital health brands. 

The Food and Drug Administration updated its guidance to note that it has not approved any at-home tests for Covid-19. A number of startups began offering private tests, for a cost, after a public shortage of testing has left many with symptoms searching for solutions.